Journal of Hepatology最新文献

筛选
英文 中文
Reply to: "Alcohol abstinence and recompensation - time to understand the 'how?'". 回复:“戒酒和补偿——是时候了解‘怎么做’了?”
IF 40.1 1区 医学
Journal of Hepatology Pub Date : 2026-09-28 DOI: 10.1016/j.jhep.2026.09.008
Benedikt Silvester Hofer, Georg Semmler, Thomas Reiberger
{"title":"Reply to: \"Alcohol abstinence and recompensation - time to understand the 'how?'\".","authors":"Benedikt Silvester Hofer, Georg Semmler, Thomas Reiberger","doi":"10.1016/j.jhep.2026.09.008","DOIUrl":"10.1016/j.jhep.2026.09.008","url":null,"abstract":"","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":" ","pages":""},"PeriodicalIF":40.1,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149074966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EBV-reactive KIR+ CX3CR1+ CD8+ T cells mediate liver transplantation tolerance. ebv反应性KIR+ CX3CR1+ CD8+ T细胞介导肝移植耐受。
IF 40.1 1区 医学
Journal of Hepatology Pub Date : 2026-09-23 DOI: 10.1016/j.jhep.2026.09.004
Yongbo Liu, Bingran Wang, Di Sun, Aiwei Zhou, Zimeng Cai, Tao Zhou, Sen Yang, Qi Pan, Yunmu Gao, Jiaqi Song, Zhipeng Zong, Wanglong Xiao, Hongyuan Liu, Taihua Yang, Zhicong Zhao, Yi Luo, Jianjun Zhang, Jianchen Fang, Zhenzhen Zhan, Linrong Lu, Yuan Liu, Qiang Xia
{"title":"EBV-reactive KIR+ CX3CR1+ CD8+ T cells mediate liver transplantation tolerance.","authors":"Yongbo Liu, Bingran Wang, Di Sun, Aiwei Zhou, Zimeng Cai, Tao Zhou, Sen Yang, Qi Pan, Yunmu Gao, Jiaqi Song, Zhipeng Zong, Wanglong Xiao, Hongyuan Liu, Taihua Yang, Zhicong Zhao, Yi Luo, Jianjun Zhang, Jianchen Fang, Zhenzhen Zhan, Linrong Lu, Yuan Liu, Qiang Xia","doi":"10.1016/j.jhep.2026.09.004","DOIUrl":"https://doi.org/10.1016/j.jhep.2026.09.004","url":null,"abstract":"<p><strong>Background & aims: </strong>Immune tolerance after transplantation reduces immunosuppression-related complications and improves the overall survival rates. The unique tolerogenic microenvironment of the liver enables a proportion of liver transplantation (LT) recipients to develop tolerance with intact liver function. However, the underlying immunological mechanisms remain unclear.</p><p><strong>Method: </strong>s: We integrated single-cell transcriptome/TCR profiling, flow cytometry, in vitro killing assays, HLA-E peptidome from a retrospective cohort including 347 LT recipients, murine LT models, and a 20-participant prospective immunosuppressant withdrawal trial in pediatric LT recipients with median 26 months follow-up.</p><p><strong>Results: </strong>We demonstrated that Epstein-Barr virus (EBV)-derived peptides can be presented by HLA-E on alloreactive CD4<sup>+</sup> T cells to prime KIR<sup>+</sup> CX3CR1<sup>+</sup> CD8<sup>+</sup> T cells, thereby promoting immune tolerance after LT. As a subset of CD8<sup>+</sup> T<sub>EMRA</sub> cells, KIR<sup>+</sup> CX3CR1<sup>+</sup> CD8<sup>+</sup> T cells utilize perforin and granzyme B to suppress alloreactive CD4<sup>+</sup> T cells after LT. In vitro analysis unveiled that the EBV-derived peptide SQAPLPCVL could stabilize HLA-E expression on alloreactive CD4<sup>+</sup> T cells and mediate recognition and elimination by KIR<sup>+</sup> CX3CR1<sup>+</sup> CD8<sup>+</sup> T cells through a TCR-dependent mechanism. Furthermore, BATF was indispensable for induction of KIR<sup>+</sup> CX3CR1<sup>+</sup> CD8<sup>+</sup> T cells. In the prospective immunosuppressant withdrawal clinical trial, the peripheral ratio of CD8<sup>+</sup> T<sub>EMRA</sub> and KIR<sup>+</sup> CX3CR1<sup>+</sup> CD8<sup>+</sup> T cells were suggested to be potentially useful in identifying tolerant recipients.</p><p><strong>Conclusions: </strong>Our study demonstrated a new immune tolerance mechanism mediated by KIR<sup>+</sup> CX3CR1<sup>+</sup> CD8<sup>+</sup> T cells and established the connection between viral infection and tolerance formation, providing new insights into tolerance-inductive strategies after transplantation.</p>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":" ","pages":""},"PeriodicalIF":40.1,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149030712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modulation instead of depletion: Rethinking B cell-targeted therapies in IgG4-related cholangitis. 调节而不是消耗:重新思考igg4相关胆管炎的B细胞靶向治疗。
IF 40.1 1区 医学
Journal of Hepatology Pub Date : 2026-09-17 DOI: 10.1016/j.jhep.2026.08.012
David C Trampert
{"title":"Modulation instead of depletion: Rethinking B cell-targeted therapies in IgG4-related cholangitis.","authors":"David C Trampert","doi":"10.1016/j.jhep.2026.08.012","DOIUrl":"https://doi.org/10.1016/j.jhep.2026.08.012","url":null,"abstract":"","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":" ","pages":""},"PeriodicalIF":40.1,"publicationDate":"2026-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148989739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Curative conversion and confounding in a bevacizumab dose comparison. 贝伐单抗剂量比较的疗效转化和混淆。
IF 40.1 1区 医学
Journal of Hepatology Pub Date : 2026-09-12 DOI: 10.1016/j.jhep.2026.08.030
Jiaju Zhao, Bin Qiao
{"title":"Curative conversion and confounding in a bevacizumab dose comparison.","authors":"Jiaju Zhao, Bin Qiao","doi":"10.1016/j.jhep.2026.08.030","DOIUrl":"https://doi.org/10.1016/j.jhep.2026.08.030","url":null,"abstract":"","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":" ","pages":""},"PeriodicalIF":40.1,"publicationDate":"2026-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148956016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Surveillance of patients at risk of liver cancer: Expert Opinions. 对肝癌高危患者监测的答复:专家意见。
IF 40.1 1区 医学
Journal of Hepatology Pub Date : 2026-09-12 DOI: 10.1016/j.jhep.2026.08.031
Maria Qurashi, Jessica Howell, Rohini Sharma
{"title":"Reply to Surveillance of patients at risk of liver cancer: Expert Opinions.","authors":"Maria Qurashi, Jessica Howell, Rohini Sharma","doi":"10.1016/j.jhep.2026.08.031","DOIUrl":"https://doi.org/10.1016/j.jhep.2026.08.031","url":null,"abstract":"","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":" ","pages":""},"PeriodicalIF":40.1,"publicationDate":"2026-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148956019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging strategies for hepatocellular carcinoma surveillance: Abbreviated MRI, biomarkers and benefit stratification. 肝细胞癌监测的新策略:简化MRI,生物标志物和获益分层。
IF 40.1 1区 医学
Journal of Hepatology Pub Date : 2026-09-02 DOI: 10.1016/j.jhep.2026.08.027
George N Ioannou, Peter Jepsen, Ian A Rowe
{"title":"Emerging strategies for hepatocellular carcinoma surveillance: Abbreviated MRI, biomarkers and benefit stratification.","authors":"George N Ioannou, Peter Jepsen, Ian A Rowe","doi":"10.1016/j.jhep.2026.08.027","DOIUrl":"10.1016/j.jhep.2026.08.027","url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) surveillance with semi-annual ultrasound and alpha-fetoprotein is recommended in clinical practice guidelines for patients with cirrhosis and selected patients with chronic hepatitis B. However, this strategy has suboptimal sensitivity for early-stage HCC and poor real-world adherence; moreover, randomised trial evidence demonstrating reduced HCC-related or all-cause mortality in patients with cirrhosis is lacking. In this expert opinion, we evaluate two emerging categories of HCC surveillance tests - abbreviated magnetic resonance imaging (aMRI) protocols and blood-based biomarker panels - and propose that, if validated, their future clinical implementation should be guided not only by HCC risk, but by expected surveillance benefit. Protocols for aMRI seek to preserve the high diagnostic accuracy of full liver-protocol MRI while reducing scan time, cost, and patient burden. Dynamic contrast-enhanced aMRI (DCE-aMRI) can establish a definitive HCC diagnosis without recall imaging and may match the accuracy of full liver-protocol MRI. Non-contrast aMRI (NC-aMRI) avoids intravenous contrast and has demonstrated superior sensitivity and specificity compared with ultrasound in recent trials. Blood-based biomarker panels, including protein-based tests (GALAD, HES 2.0) and circulating tumour DNA-based assays (Oncoguard, HelioLiver) may improve adherence, but face methodological challenges and require rigorous, prospective longitudinal evaluation to determine whether they result not only in earlier actionable detection but also better clinical outcomes. We argue that selecting which patients should receive enhanced surveillance requires moving beyond risk stratification towards benefit stratification, i.e. basing surveillance recommendations not only on the patient's risk of developing HCC, but also on the probability that earlier-stage detection and receipt of effective treatment enabled by surveillance will improve clinical outcomes. Patients at the highest HCC risk do not necessarily stand to gain the most from earlier detection, underscoring the need for pragmatic frameworks and prediction tools that estimate individualised surveillance benefit.</p>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":" ","pages":""},"PeriodicalIF":40.1,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148880856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Silent but persistent: Failure of continuous tenofovir based ART to prevent HBV and HDV reactivation under chemotherapy in an HBsAg-negative patient living with HIV. 沉默但持续:持续的替诺福韦为基础的抗逆转录病毒治疗在一个hbsag阴性的HIV患者化疗下预防HBV和HDV再激活失败。
IF 40.1 1区 医学
Journal of Hepatology Pub Date : 2026-09-02 DOI: 10.1016/j.jhep.2026.08.010
Lisa Sophie Pflüger, Katja Giersch, Julian Schulze Zur Wiesch, Marc Lütgehetmann
{"title":"Silent but persistent: Failure of continuous tenofovir based ART to prevent HBV and HDV reactivation under chemotherapy in an HBsAg-negative patient living with HIV.","authors":"Lisa Sophie Pflüger, Katja Giersch, Julian Schulze Zur Wiesch, Marc Lütgehetmann","doi":"10.1016/j.jhep.2026.08.010","DOIUrl":"https://doi.org/10.1016/j.jhep.2026.08.010","url":null,"abstract":"","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":" ","pages":""},"PeriodicalIF":40.1,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148880858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mouse models of acute and chronic hepatitis E virus infection 急性和慢性戊型肝炎病毒感染小鼠模型
IF 25.7 1区 医学
Journal of Hepatology Pub Date : 2026-09-01 DOI: 10.1016/j.jhep.2026.08.034
Tianxu Liu,Xinyue Yang,Baixun Li,Qing Fan,Zihao Yu,Dong Ying,Yuebao Li,Wei Zhang,Jiajing Wu,Peiyu Jiang,Liwei Zheng,Hongzhen Mao,Guochao Wei,Yanning Liu,Xin Yin,Fengmin Lu,Zizheng Zheng,Weigang Zhang,Cheng-Feng Qin,André Gömer,Nicola Frericks,Eike Steinmann,Lei Qin,Yunjie Lu,Bei Jiang,Lin Wang
{"title":"Mouse models of acute and chronic hepatitis E virus infection","authors":"Tianxu Liu,Xinyue Yang,Baixun Li,Qing Fan,Zihao Yu,Dong Ying,Yuebao Li,Wei Zhang,Jiajing Wu,Peiyu Jiang,Liwei Zheng,Hongzhen Mao,Guochao Wei,Yanning Liu,Xin Yin,Fengmin Lu,Zizheng Zheng,Weigang Zhang,Cheng-Feng Qin,André Gömer,Nicola Frericks,Eike Steinmann,Lei Qin,Yunjie Lu,Bei Jiang,Lin Wang","doi":"10.1016/j.jhep.2026.08.034","DOIUrl":"https://doi.org/10.1016/j.jhep.2026.08.034","url":null,"abstract":"","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"24 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148923140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-Transplant Hepatitis D Breakthrough Driven by Integrant-Derived HBsAg from an Extrahepatic HCC Metastasis 肝外肝细胞癌转移中整合物来源的HBsAg驱动移植后D型肝炎的突破
IF 25.7 1区 医学
Journal of Hepatology Pub Date : 2026-09-01 DOI: 10.1016/j.jhep.2026.08.029
Lorenza Di Marco,Nicola De Maria,Daniele Lombardo,Giovanni Raimondo,Teresa Pollicino,Maria Paola Anolli,Giacomo Ciusa,Antonio Colecchia,Elisabetta Degasperi,Fabrizio Di Benedetto,Stefano Di Sandro,Giovanni Dolci,Massimo Dominici,Domenico Giosa,Giovanni Guaraldi,Pietro Lampertico,Marco Maggioni,Cristina Musolino,David James Pinato,Alessandra Pivetti,Adriana Romanzi,Massimiliano Salati,Andrea Spallanzani
{"title":"Post-Transplant Hepatitis D Breakthrough Driven by Integrant-Derived HBsAg from an Extrahepatic HCC Metastasis","authors":"Lorenza Di Marco,Nicola De Maria,Daniele Lombardo,Giovanni Raimondo,Teresa Pollicino,Maria Paola Anolli,Giacomo Ciusa,Antonio Colecchia,Elisabetta Degasperi,Fabrizio Di Benedetto,Stefano Di Sandro,Giovanni Dolci,Massimo Dominici,Domenico Giosa,Giovanni Guaraldi,Pietro Lampertico,Marco Maggioni,Cristina Musolino,David James Pinato,Alessandra Pivetti,Adriana Romanzi,Massimiliano Salati,Andrea Spallanzani","doi":"10.1016/j.jhep.2026.08.029","DOIUrl":"https://doi.org/10.1016/j.jhep.2026.08.029","url":null,"abstract":"","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"3 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148893908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Restoration of aged liver regeneration by youthful systemic factors via LTβ-driven hepatocyte reprogramming 通过ltβ驱动的肝细胞重编程,通过年轻的系统因子恢复衰老的肝脏再生
IF 25.7 1区 医学
Journal of Hepatology Pub Date : 2026-09-01 DOI: 10.1016/j.jhep.2026.08.036
Jiang Chenhao,Han Lu,Liu Yasong,Zhang Jianhao,Chen Huaxin,Wen Xinyun,Chi Xianda,Fan Linda,Li Tianyi,Shi Shaojun,Chen Sunrui,Xiao Jiaqi,Lv Xing,Zhang Jiebin,Zhao Xuegang,Zhang Yujun,Liu Jianrong,Zhang Xu,Lv Guo,Qiu Yuan,Yao Jia,Zeng Kaining,Li Haibo,Lu Tongyu,Ye Linsen,Fu Binsheng,Li Hua,Yi Shuhong,Liu Wei,Zhang Qi,Chen Guihua,Cai Jianye,Xiang Andy Peng,Zhang Yingcai,Sui Xin,Yang Yang
{"title":"Restoration of aged liver regeneration by youthful systemic factors via LTβ-driven hepatocyte reprogramming","authors":"Jiang Chenhao,Han Lu,Liu Yasong,Zhang Jianhao,Chen Huaxin,Wen Xinyun,Chi Xianda,Fan Linda,Li Tianyi,Shi Shaojun,Chen Sunrui,Xiao Jiaqi,Lv Xing,Zhang Jiebin,Zhao Xuegang,Zhang Yujun,Liu Jianrong,Zhang Xu,Lv Guo,Qiu Yuan,Yao Jia,Zeng Kaining,Li Haibo,Lu Tongyu,Ye Linsen,Fu Binsheng,Li Hua,Yi Shuhong,Liu Wei,Zhang Qi,Chen Guihua,Cai Jianye,Xiang Andy Peng,Zhang Yingcai,Sui Xin,Yang Yang","doi":"10.1016/j.jhep.2026.08.036","DOIUrl":"https://doi.org/10.1016/j.jhep.2026.08.036","url":null,"abstract":"","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"54 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149020504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书